239 related articles for article (PubMed ID: 33541320)
21. Rising Incidence of Intestinal Infections in Inflammatory Bowel Disease: A Nationwide Analysis.
Barber GE; Hendler S; Okafor P; Limsui D; Limketkai BN
Inflamm Bowel Dis; 2018 Jul; 24(8):1849-1856. PubMed ID: 29722832
[TBL] [Abstract][Full Text] [Related]
22. Home Infliximab Infusions Are Associated With Suboptimal Outcomes Without Cost Savings in Inflammatory Bowel Diseases.
Giese-Kim N; Wu M; Dehghan M; Sceats LA; Park KT
Am J Gastroenterol; 2020 Oct; 115(10):1698-1706. PubMed ID: 32701731
[TBL] [Abstract][Full Text] [Related]
23. Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis.
Nguyen NH; Kurnool S; Dulai PS; Boland BS; Sandborn WJ; Singh S
Inflamm Bowel Dis; 2020 Aug; 26(9):1429-1435. PubMed ID: 31748806
[TBL] [Abstract][Full Text] [Related]
24. Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease.
Benchimol EI; Mack DR; Nguyen GC; Snapper SB; Li W; Mojaverian N; Quach P; Muise AM
Gastroenterology; 2014 Oct; 147(4):803-813.e7; quiz e14-5. PubMed ID: 24951840
[TBL] [Abstract][Full Text] [Related]
25. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
[TBL] [Abstract][Full Text] [Related]
26. Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.
Buie MJ; Coward S; Shaheen AA; Holroyd-Leduc J; Hracs L; Ma C; Panaccione R; Benchimol EI; Bernstein CN; Bitton A; Otley AR; Jones JL; Murthy SK; Ellen Kuenzig M; Peña-Sánchez JN; Targownik LE; Singh H; Avina-Zubieta A; Kaplan GG
Inflamm Bowel Dis; 2023 Oct; 29(10):1536-1545. PubMed ID: 36917200
[TBL] [Abstract][Full Text] [Related]
27. Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease-Are We There Yet?
Levartovsky A; Barash Y; Ben-Horin S; Ungar B; Klang E; Soffer S; Kopylov U
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32858826
[TBL] [Abstract][Full Text] [Related]
28. [Retrospective analysis of case histories of patients with ulcerative colitis and Crohn's disease].
Zvirbliene A; Kiudelis G; Kupcinskas L
Medicina (Kaunas); 2003; 39(8):745-50. PubMed ID: 12960453
[TBL] [Abstract][Full Text] [Related]
29. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
30. Hospitalizations for Inflammatory Bowel Disease Among Medicare Fee-for-Service Beneficiaries - United States, 1999-2017.
Xu F; Wheaton AG; Liu Y; Lu H; Greenlund KJ
MMWR Morb Mortal Wkly Rep; 2019 Dec; 68(49):1134-1138. PubMed ID: 31830006
[TBL] [Abstract][Full Text] [Related]
31. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
[TBL] [Abstract][Full Text] [Related]
32. Recurrence of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease: The RECIDIVISM Study.
Razik R; Rumman A; Bahreini Z; McGeer A; Nguyen GC
Am J Gastroenterol; 2016 Aug; 111(8):1141-6. PubMed ID: 27215924
[TBL] [Abstract][Full Text] [Related]
33. Hospitalizations and in-hospital mortality for inflammatory bowel disease in Brazil.
Guedes ALV; Lorentz AL; Rios LFAR; Freitas BC; Dias AGN; Uhlein ALE; Vieira Neto FO; Jesus JFS; Torres TSN; Rocha R; Andrade VD; Santana GO
World J Gastrointest Pharmacol Ther; 2022 Jan; 13(1):1-10. PubMed ID: 35116179
[TBL] [Abstract][Full Text] [Related]
34. Infection Risk With Biologic Therapy in Patients With Inflammatory Bowel Disease.
Hindryckx P; Novak G; Bonovas S; Peyrin-Biroulet L; Danese S
Clin Pharmacol Ther; 2017 Oct; 102(4):633-641. PubMed ID: 28699217
[TBL] [Abstract][Full Text] [Related]
35. Trends in hospitalizations of children with inflammatory bowel disease within the United States from 2000 to 2009.
Pant C; Anderson MP; Deshpande A; Grunow JE; O'Connor JA; Philpott JR; Sferra TJ
J Investig Med; 2013 Aug; 61(6):1036-8. PubMed ID: 23797749
[TBL] [Abstract][Full Text] [Related]
36. [Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000-2014].
Guan DX; Yu FH; Wang GL; Zhou J; Wang DY; Nie XL; Xu XW
Zhonghua Er Ke Za Zhi; 2017 Jul; 55(7):493-498. PubMed ID: 28728256
[No Abstract] [Full Text] [Related]
37. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
[TBL] [Abstract][Full Text] [Related]
38. Variation in the Care of Children with Inflammatory Bowel Disease Within and Across Canadian Provinces: A Multi-Province Population-Based Cohort Study.
Kuenzig ME; Stukel TA; Carroll MW; Kaplan GG; Otley AR; Singh H; Bitton A; Fung SG; Spruin S; Coward S; Cui Y; Nugent Z; Griffiths AM; Mack DR; Jacobson K; Nguyen GC; Targownik LE; El-Matary W; Bernstein CN; Dummer TJB; Jones JL; Lix LM; Murthy SK; Peña-Sánchez JN; Nasiri S; Benchimol EI;
Clin Epidemiol; 2024; 16():91-108. PubMed ID: 38374886
[TBL] [Abstract][Full Text] [Related]
39. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
40. Are Surgical Rates Decreasing in the Biological Era In IBD?
Candido FD; Fiorino G; Spadaccini M; Danese S; Spinelli A
Curr Drug Targets; 2019; 20(13):1356-1362. PubMed ID: 31465283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
